Application of AI-driven Xanthos Platform for Designing Protein Degraders
In contrast to the discovery of "traditional drugs" such as small molecule inhibitors and most biologics, the development of protein …
From Our Partners
Cyclica's Chemical Probes for DCAF1
Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
This is a sponsored case study republished from ScienceExchange.com Over the past decade, the biopharmaceutical industry has undergone a massive …
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Bioz provides advanced life science experimentation insights to scientists in two key formats, first on the Bioz platform which showcases …
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by Biocompare.com Every marketer feels pressure to demonstrate results for their marketing spend. Executives in the life sciences industry …
This South Korean Company is at the Forefront of AI-driven Drug Discovery
There is a new generation of tech-savvy drug discovery companies, applying the power of artificial intelligence (AI) to accelerate and …
Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics
There is a new wave of innovation that is sweeping through pharmaceutical drug discovery: targeted protein degradation (TPD). TPD is …
Combining AI and Quantum Mechanics to Improve Drug and Vaccine Discovery
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …
Breakthrough Technology Solving Characterization Challenges and Accelerating Biopharmaceutical Drug Development
High-Resolution Ion Mobility Mass Spectrometry (HRIM-MS) has emerged as a promising new separations technique in the biopharmaceutical and clinical market. …